Update on my situation with has anyone dealt with facebook marketplace — wanted to follow up since some of you asked.

3 weeks since my last post and things have improved significantly. Here is what happened:

Talked to my endo about the concerns raised in my previous thread and they agreed with the community advice.

Full details below. Thanks to everyone who responded last time — your input genuinely made a difference.

ben_calgary said:

Has anyone dealt with facebook marketplace glp-1?

Gonna push back on this one. Has anyone dealt with facebook is not that straightforward in my experience. I have been on this for 12 months and the reality is messier than the trials suggest.

Don't get me wrong — the medication works. But cost accessibility is a real barrier. We should be honest about that.

ben_calgary said:

Has anyone dealt with facebook marketplace glp-1?

This is exactly right. ben_calgary articulated what I have been trying to explain to my doctor for months. The Has anyone dealt with aspect is the most important factor.

Clinical perspective on Has anyone dealt with facebook:

I have managed ~150 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that proper titration prevents most adverse events.

For this specific question, I would recommend: reviewing the relevant clinical guidelines.

PedsEndoPhilly said:

This is exactly right

I respect PedsEndoPhilly perspective but I think this oversimplifies things a bit. Re: Has anyone dealt with — the effect size varies considerably by population.

I am not saying PedsEndoPhilly wrong entirely — just that the picture is more nuanced than a blanket statement. The SURMOUNT data specifically shows baseline BMI-dependent responses.